These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2007321)

  • 1. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefpiramide kinetics and plasma protein binding in cholestasis.
    Demontes-Mainard F; Vinçon G; Labat L; Amouretti M; Necciari J; Kieffer G; Bannwarth B
    Br J Clin Pharmacol; 1994 Mar; 37(3):295-7. PubMed ID: 8198940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
    Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
    Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alfentanil pharmacokinetics in patients with cirrhosis.
    Ferrier C; Marty J; Bouffard Y; Haberer JP; Levron JC; Duvaldestin P
    Anesthesiology; 1985 Apr; 62(4):480-4. PubMed ID: 3920934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefpiramide (SM-1652) in humans.
    Nakagawa K; Koyama M; Matsui H; Ikeda C; Yano K; Nakatsuru N; Yoshinaga K; Noguchi T
    Antimicrob Agents Chemother; 1984 Feb; 25(2):221-5. PubMed ID: 6712202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopental pharmacokinetics in patients with cirrhosis.
    Pandele G; Chaux F; Salvadori C; Farinotti M; Duvaldestin P
    Anesthesiology; 1983 Aug; 59(2):123-6. PubMed ID: 6869869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pefloxacin kinetics in cirrhosis.
    Danan G; Montay G; Cunci R; Erlinger S
    Clin Pharmacol Ther; 1985 Oct; 38(4):439-42. PubMed ID: 3862496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tubular mechanisms for excretion of cefpiramide (SM-1652) in association with its long-lasting pharmacokinetic properties.
    Matsui H; Okuda T
    J Pharmacobiodyn; 1988 Feb; 11(2):67-73. PubMed ID: 3379566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function.
    Conte JE
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1585-8. PubMed ID: 3435107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and disposition of sulfisoxazole in alcoholic cirrhosis.
    Cello JP; Oie S
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):1-12. PubMed ID: 4020620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil disposition and elimination in cirrhosis.
    Janssen U; Walker S; Maier K; von Gaisberg U; Klotz U
    Clin Pharmacol Ther; 1989 Sep; 46(3):317-23. PubMed ID: 2505960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Drugs Exp Clin Res; 1988; 14(8):519-27. PubMed ID: 3248507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naproxen disposition in patients with alcoholic cirrhosis.
    Williams RL; Upton RA; Cello JP; Jones RM; Blitstein M; Kelly J; Nierenburg D
    Eur J Clin Pharmacol; 1984; 27(3):291-6. PubMed ID: 6510456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
    Magueur E; Hagege H; Attali P; Singlas E; Etienne JP; Taburet AM
    Br J Clin Pharmacol; 1991 Feb; 31(2):185-7. PubMed ID: 2049236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects.
    Pond SM; Tong T; Benowitz NL; Jacob P; Rigod J
    Clin Pharmacol Ther; 1981 Aug; 30(2):183-8. PubMed ID: 7249503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
    Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sufentanil pharmacokinetics in patients with cirrhosis.
    Chauvin M; Ferrier C; Haberer JP; Spielvogel C; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1989 Jan; 68(1):1-4. PubMed ID: 2521279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.
    Pentikainen PJ; Neuvonen PJ; Tarpila S; Syvälahti E
    Br Med J; 1978 Sep; 2(6141):861-3. PubMed ID: 709096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects.
    Hall KW; Nightingale CH; Gibaldi M; Nelson E; Bates TR; DiSanto AR
    J Clin Pharmacol; 1982 Jul; 22(7):321-5. PubMed ID: 7107981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.